• 615 Citations
  • 9 h-Index
20092020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Pingali is board certified by the American Board of Internal Medicine in medical oncology and hematology. His primary focus is on hematologic malignancies and stem cell transplantation. After completing his medical training in India, Dr. Pingali received training in various reputable programs in the United Kingdom as part of senior house officer training after which he moved to the United States. He completed his residency in internal medicine at Gundersen Lutheran Medical Center in Wisconsin. He then completed a fellowship in hematology and oncology at the Medical College of Wisconsin, and a fellowship in stem cell transplantation at the University of Texas MD Anderson Cancer Center.

Dr. Pingali is a member of the American Society of Clinical Oncology, American Society of Hematology and the American Society for Blood and Marrow Transplantation. He sees patients at Houston Methodist Hospital.

Research Area Keywords

  • Cancer
  • Clinical Translation & Trials
  • Molecular Medicine

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

  • 615 Citations
  • 9 h-Index
  • 29 Article
  • 2 Review article
  • 1 Comment/debate
  • 1 Letter

Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors

Anand, K., Sahu, G., Burns, E., Ensor, A., Ensor, J., Pingali, S. R., Subbiah, V. & Iyer, S. P., Aug 18 2020, In : ESMO Open. 5, 4, e000866.

Research output: Contribution to journalArticle

Open Access
  • Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review

    Anand, K., Burns, E. A., Ensor, J., Rice, L. & Pingali, S. R., Jan 2020, In : Clinical Lymphoma, Myeloma and Leukemia. 20, 1, p. 18-23 6 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Radiation therapy in primary mediastinal large B-cell lymphoma treated with DA-R-EPOCH

    Gentille, C., Anand, K., Dalwadi, S., Puri, A., Farach, A. & Pingali, S. R., Jul 1 2020, In : Clinical Case Reports. 8, 7, p. 1153-1155 3 p.

    Research output: Contribution to journalArticle

  • T-cell lymphoma secondary to checkpoint inhibitor therapy

    Anand, K., Ensor, Jr., J. E., Pingali, S. R., Hwu, P., Duvic, M., Chiang, S., Miranda, R., Zu, Y. & Iyer, S., Feb 28 2020, In : Journal for immunotherapy of cancer. 8, 1, e000104.

    Research output: Contribution to journalArticle